PT  - JOURNAL ARTICLE
AU  - Beisenova, Aidana
AU  - Adi, Wihan
AU  - Bashar, S. Janna
AU  - Velmurugan, Monniiesh
AU  - Germanson, Kenzie B.
AU  - Shelef, Miriam A.
AU  - Yesilkoy, Filiz
TI  - Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
AID  - 10.1101/2023.02.06.23285535
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.06.23285535
4099  - http://medrxiv.org/content/early/2023/02/08/2023.02.06.23285535.short
4100  - http://medrxiv.org/content/early/2023/02/08/2023.02.06.23285535.full
AB  - Serological population surveillance can elucidate immunity landscapes against SARS-CoV-2 variants and are critical in monitoring infectious disease spread, evolution, and outbreak risks. However, current serological tests fall short of capturing complex humoral immune responses from different communities. Here, we report a machine-learning (ML)-aided nanobiosensor that can simultaneously quantify antibodies against the ancestral strain and Omicron variants of SARS-CoV-2 with epitope resolution. Our approach is based on a multiplexed, rapid, and label-free nanoplasmonic biosensor, which can detect past infection and vaccination status and is sensitive to SARS-CoV-2 variants. After training an ML model with antigen-specific antibody datasets from four COVID-19 immunity groups (naïve, convalescent, vaccinated, and convalescent-vaccinated), we tested our approach on 100 blind blood samples collected in Dane County, WI. Our results are consistent with public epidemiological data, demonstrating that our user-friendly and field-deployable nanobiosensor can capture community-representative public health trends and help manage COVID-19 and future outbreaks.Competing Interest StatementM. A. S. is listed as an inventor on a patent filed related to this study (PCT/US2021/051143; IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE). All other authors declare that they have no competing interests. Funding StatementWisconsin Alumni Research Foundation, School of Medicine and Public Health, University of Wisconsin Madison (award number 4791).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the main text and Supplementary Material.